Exhibit 10.1



 Exhibit 10.1 

SEPARATION AND RELEASE AGREEMENT 

This Separation and Release Agreement (this “Release Agreement”) is dated as of September 10, 2010, and entered
into by and between Nick J. Grujich, an individual (“Executive”) and Catalyst Health Solutions, Inc. (together with any successor thereto, the “Company”). 

WHEREAS, Executive has been employed by the Company; 

WHEREAS, Executive wishes to resign from the Company; 

WHEREAS, Executive’s employment by the Company will terminate or be terminated effective as of September 20, 2010 (the
“Termination Date”), and the parties desire to enter into this Release Agreement upon the terms set forth herein; and 

WHEREAS, Executive is party to that certain Employment Agreement between Executive and the Company, dated as of February 28,
2008, and as amended effective June 22, 2010 (the “Employment Agreement”), including the Confidentiality and Non-Competition Addendum attached in Schedule 10-1 thereto (the “Addendum”). 

NOW, THEREFORE, in consideration of the covenants undertaken and the releases contained in this Release Agreement, and in
consideration of the Company’s desire and willingness to pay severance benefits (conditioned upon the terms of this Release Agreement), to which Executive is not otherwise entitled, the parties hereby agree as follows: 

1. Separation from Service; Resignation. Executive’s employment with the Company will terminate, or be terminated, on the
Termination Date. Effective as of the Termination Date, Executive hereby resigns from his employment with the Company, and further resigns from any other officer or director positions Executive holds with the Company and/or any of its affiliated
entities. 
 2. Severance. Subject to Executive’s continued compliance with the terms and conditions of this Release
Agreement and the Addendum, and further subject to Executive’s non-revocation of this Release Agreement, the severance amounts and benefits payable or to be provided to Executive in accordance with the terms hereunder are set forth on
Exhibit A attached hereto (the “Severance Schedule”). Executive agrees that, except as provided below, and notwithstanding the terms and conditions of the Employment Agreement, the amounts set forth on the Severance Schedule
reflect the entire amount of the severance payments and benefits payable or to be provided to Executive hereunder and that such amounts shall be subject to all tax withholdings required by applicable law. 

3. Equity Awards. As of the date hereof, Executive holds the stock option(s) listed on Exhibit B attached hereto, to
purchase shares of the Company’s common stock. As of the date hereof, Executive holds unvested shares of restricted common stock of the Company listed on Exhibit B attached hereto. All unvested stock options and unvested shares of
restricted common stock held by Executive as of the Termination Date shall be forfeited on the Termination Date. 
  


					
	         Executive Initials	  	1	  	









 4. Confidentiality and Non-Competition Addendum. Notwithstanding anything to the
contrary contained in this Release Agreement or any other agreement, the Company and Executive hereby agree that the Addendum shall survive execution of this Release Agreement and the termination of the Employment Agreement pursuant to
Section 5 hereof. Executive hereby agrees that he shall continue to abide by the terms, conditions and restrictions of the Addendum in accordance with the provisions thereof; provided, however, that notwithstanding anything to the
contrary contained in the first sentence of Section 4.1(B) of the Addendum, the Company and Executive hereby agree that the Executive shall be permitted to accept employment, consult or otherwise provide services in any capacity to any person,
partnership or entity (including any affiliate of such entity) beginning October 1, 2010 except for the entity presently providing prescription claims processing to the Company. Executive agrees that he will comply with, or has already complied
with, Section III of the Addendum as of the Termination Date. 
 5. Employment Agreement. Effective as of the date
hereof, the Company and Executive hereby agree that (i) the Employment Agreement (except for the Addendum) shall be terminated and of no further force or effect and (ii) neither the Company nor Executive shall have any further rights or
obligations (including without limitation any obligations of the Company to make any severance or other payments to Executive) under the Employment Agreement (except for the Addendum) from and after the date hereof; provided, that Executive shall be
entitled to receive payment for base salary earned prior to the Termination Date and not paid prior to the Termination Date, reimbursement for any unreimbursed business expenses properly incurred by Executive in accordance with Company policy prior
to the Termination Date and any accrued but unpaid vacation, to the extent payable pursuant to Company policy. 
 6.
Release. Executive, on behalf of himself, his descendants, dependents, heirs, executors, administrators, assigns, and successors, and each of them, hereby covenants not to sue and fully releases and discharges the Company and each of its
parents, subsidiaries and affiliates, past and present, as well as each of their trustees, directors, officers, members, managers, partners, agents, attorneys, insurers, employees, stockholders, representatives, assigns, and successors, past and
present, and each of them, hereinafter together and collectively referred to as the “Releasees,” with respect to and from any and all claims, wages, demands, rights, liens, agreements or contracts (written or oral), covenants,
actions, suits, causes of action, obligations, debts, costs, expenses, attorneys’ fees, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether now known or unknown, suspected or unsuspected,
and whether or not concealed or hidden (each, a “Claim”), which Executive now owns or holds or Executive has at any time heretofore owned or held or may in the future hold as against any of said Releasees arising out of or in any
way connected with Executive’s service as an officer, director, employee, member or manager of any Releasee and/or Executive’s separation from his position as an officer, director, employee, manager and/or member, as applicable, of any
Releasee, resulting from any act or omission by or on the part of said Releasees, or any of them, committed or omitted prior to the Termination Date including, without limiting the generality of the foregoing, any Claim under Title VII of the Civil
Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act of 1993, the Worker Adjustment and Retraining Notification Act (or any similar state, local or foreign law), the Maryland Fair Employment Practices Act, the
Maryland Wage and Hour Law, or any other federal, state or local law, regulation, or ordinance, or any Claim for compensation or 

 


					
	         Executive Initials	  	2	  	









 
benefits, including any severance pay, bonus, sick leave, holiday pay, vacation pay, life insurance, disability insurance, health or medical insurance, retirement benefits, workers’
compensation or any other fringe benefit; provided that such release shall not apply to any of the following: (1) any right to indemnification that Executive may have pursuant to the bylaws (or similar governing document) of the Company or any
of its parents, subsidiaries or other affiliates, the certificate of incorporation (or similar governing document) of the Company or any of its parents, subsidiaries or other affiliates, or pursuant to any statute, law, or common law principle;
(2) any rights that Executive may have to insurance coverage for any losses, damages, fees or other expenses under any Company (or parent, subsidiary or affiliate) directors and officers liability insurance policy; (3) any rights to
continued medical or dental coverage that Executive may have under COBRA (or similar applicable state law); or (4) any rights to payment of vested benefits (other than severance benefits and, for the avoidance of doubt, any right to bonus
amounts) that Executive may have under any other benefit plan sponsored or maintained by the Company. In addition, this Release Agreement does not cover any Claim that cannot be so released as a matter of applicable law. Executive acknowledges and
agrees that he has received any and all leave and other benefits that he has been and is entitled to pursuant to the Family and Medical Leave Act of 1993. 

Company hereby releases Executive with respect to and from any and all claims, wages, demands, rights, liens, agreements or contracts (written or oral),
covenants, actions, suits, causes of action, obligations, debts, costs, expenses, attorneys’ fees, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise (each, a “Company Claim”),
which Company now owns or holds, has at any time heretofore owned or held or may in the future hold against Executive for any act taken by Executive in the conduct of his duties as an officer, director, employee, member or manager of Company
committed prior to the Termination Date; provided, that Company does not release Executive from any Company Claim related to or arising from (i) any material act of misconduct taken by Executive to the extent no executive officer of the
Company, other than Executive, is aware of such material act of misconduct as of the date of this Release Agreement, (ii) any crimes committed by Executive or (iii) any conduct constituting fraud or intentional misrepresentation.

 7. ADEA Waiver. Executive expressly acknowledges and agrees that by entering into this Release Agreement, Executive is
waiving any and all rights or Claims that he may have arising under the Age Discrimination in Employment Act of 1967, as amended (the “ADEA”), which have arisen on or before the Termination Date. Executive further expressly
acknowledges and agrees that: 
 A. In return for this Release Agreement, the Executive will be entitled to
receive consideration beyond that which the Executive was already entitled to receive before entering into this Release Agreement; 

B. Executive is hereby advised in writing by this Release Agreement to consult with an attorney before signing this
Release Agreement; 
 C. Executive has voluntarily chosen to enter into this Release Agreement and has not been
forced or pressured in any way to sign it; 
  


					
	         Executive Initials	  	3	  	









 D. Executive is hereby informed that he has twenty-one (21) days within
which to consider this Release Agreement; 
 E. Executive is hereby informed that he has seven (7) days
following the date he executes this Release Agreement in which to revoke this Release Agreement, and this Release Agreement will become null and void if Executive elects revocation during that time. Any revocation must be in writing and must be
delivered personally or sent by facsimile or certified or registered mail, postage prepaid, to the Company during the seven-day revocation period, as follows: 

Catalyst Health Solutions, Inc. 

800 King Farm Boulevard 

Rockville, MD 20850 

Attention: General Counsel 

In the event that Executive timely exercises his right of revocation, neither the Company nor Executive will have any
obligations under this Release Agreement; and 
 F. Nothing in this Release Agreement prevents or precludes
Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law.

 8. No Transferred Claims. Executive warrants and represents that the Executive has not heretofore assigned or
transferred to any person not a party to this Release Agreement any released matter or any part or portion thereof and he shall defend, indemnify and hold the Company and each of its affiliates harmless from and against any claim (including the
payment of attorneys’ fees and costs actually incurred whether or not litigation is commenced) based on or in connection with or arising out of any such assignment or transfer made, purported or claimed. 

9. Severability. It is the desire and intent of the parties hereto that the provisions of this Release Agreement be enforced to
the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Release Agreement shall be adjudicated by a court of competent
jurisdiction to be invalid, prohibited or unenforceable under any present or future law, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Release Agreement or affecting the validity
or enforceability of such provision in any other jurisdiction; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of this Release Agreement, a legal, valid and enforceable provision as similar
in terms to such invalid or unenforceable provision as may be possible. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Release Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 

 


					
	         Executive Initials	  	4	  	









 10. Counterparts. This Release Agreement may be executed in separate counterparts,
each of which is deemed to be an original and all of which taken together constitute one and the same agreement. 
 11.
Governing Law. THIS RELEASE AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH UNITED STATES FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY UNITED STATES FEDERAL LAW, THE LAWS OF THE STATE OF MARYLAND, WITHOUT GIVING EFFECT TO
ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF MARYLAND OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN UNITED STATES FEDERAL LAW AND THE LAW OF THE STATE OF MARYLAND TO BE APPLIED. IN
FURTHERANCE OF THE FOREGOING, APPLICABLE FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY APPLICABLE FEDERAL LAW, THE INTERNAL LAW OF THE STATE OF MARYLAND, WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS RELEASE AGREEMENT, EVEN IF UNDER
SUCH JURISDICTION’S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY. 

12. Amendment and Waiver. The provisions of this Release Agreement may be amended and waived only with the prior written consent
of the Company and Executive, and no course of conduct or failure or delay in enforcing the provisions of this Release Agreement shall be construed as a waiver of such provisions or affect the validity, binding effect or enforceability of this
Release Agreement or any provision hereof. 
 13. Remedies. Executive recognizes and acknowledges that a breach of the
covenants contained in this Release Agreement will cause irreparable damage to the Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate.
Accordingly, in addition to any other remedy to which the Company may be entitled, at law or in equity, the Company will be entitled (i) to an injunction or injunctions to prevent breaches of the provisions of this Release Agreement (whether
actual or contemplated) and to enforce specifically the provisions of this Release Agreement, and (ii) to set off against any compensation and other payments of any kind owed or payable to Executive, any amounts owing to the Company as a result
of a breach of this Release Agreement or otherwise, including the right to stop the payment of amounts pursuant to the Severance Schedule. The rights and remedies provided to the Company in this Release Agreement are cumulative and are in addition
to all other rights and remedies provided by law or in equity. Without limiting the foregoing, Executive agrees that the Company would be entitled to recover money from Executive if this Release Agreement were violated. 

14. Descriptive Headings. The descriptive headings of this Release Agreement are inserted for convenience only and do not
constitute a part of this Release Agreement. 
 15. Construction. Where specific language is used to clarify by example a
general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates. The 

 


					
	         Executive Initials	  	5	  	









 
language used in this Release Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any
party. 
 16. No Wrongdoing. This Release Agreement does not constitute an adjudication or finding on the merits and is
not, and shall not be construed as, an admission or acknowledgment by any party of any violation of any policy, procedure, state or federal law or regulation, or any unlawful or improper act or conduct, all of which is expressly denied. Moreover,
neither this Release Agreement nor anything in this Release Agreement shall be construed to be, or shall be, admissible in any proceeding as evidence of or an admission by any party of any violation of any policy, procedure, state or federal law or
regulation, or any unlawful or improper act or conduct. This Release Agreement may be introduced, however, in any proceeding to enforce this Release Agreement. 

17. Legal Counsel. The parties hereto recognize that this Release Agreement is a legally binding contract and acknowledge and
agree that they have had the opportunity to consult with legal counsel of their choice. Executive acknowledges and agrees that he has read and understands this Release Agreement completely, is entering into it freely and voluntarily, and had been
advised to seek counsel prior to entering into this Release Agreement and he has had ample opportunity to do so. 
 18. Nouns
and Pronouns. Whenever the context may require, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural and vice-versa. 

19. Section 409A. For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury
Regulation Section 1.409A-2(b)(2)(iii)), each payment that the Executive may be eligible to receive under this Release Agreement shall be treated as a separate and distinct payment. To the extent applicable, this Agreement shall be interpreted
in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative guidance issued thereunder, including without limitation any such regulations or other such guidance that may be issued after the date
hereof. 
 [Remainder of page intentionally left blank] 

 


					
	         Executive Initials	  	6	  	









 The undersigned have read and understand the consequences of this Release Agreement and
voluntarily sign it. 
  

			
	EXECUTIVE
		
	By:	 	  

		 	Nick J. Grujich
	
	CATALYST HEALTH SOLUTIONS, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  




 


					
	         Executive Initials	  	7	  	









 Exhibit A 

Severance Schedule 

A. Total Cash Payment 
 Executive shall
be entitled to receive an aggregate cash payment equal to $236,666.67, which amount shall be paid in a lump sum within five (5) business days after the date the Release Agreement is no longer revocable by the Executive under applicable law, and
shall be subject to tax withholdings in accordance with applicable law and as provided in Section 2 of the Release Agreement. 
 B.
Other Benefits 
 Continued medical benefit coverage pursuant to COBRA for Executive, Executive’s spouse and eligible dependents for a
period of twelve (12) months after the Termination Date. In order to allow the continuation of such medical benefits, Executive agrees to timely elect COBRA continuation coverage for himself, his spouse and eligible dependents and the Company
will make twelve (12) monthly premium payments directly to the provider of such medical benefits. 
  


					
	         Executive Initials	  	8	  	









 Exhibit B 

Outstanding Stock Option 
  

			
	 Unvested Portion:
	  	[0]
	 Vested
Portion*:
	  	[100,000]
	 Total:
	  	[0]


 

	*	Executive hereby agrees, that notwithstanding anything contained in any stock option award agreement, the Employment Agreement, or any other agreement, the unvested
portion of such outstanding stock option(s) shall be forfeited on the Termination Date. The vested portion of such outstanding stock option(s) shall be exercisable for the period of time set forth in the applicable stock option award agreement and
any portion of such vested and outstanding stock option(s) not exercised during such period of time shall be immediately forfeited. 


Outstanding Unvested Shares of Restricted Stock 
  

			
	 Unvested
Shares of
 Restricted Stock**:
	  	[60,250]
	
Total:
	  	[60,250]


 

	**	Executive hereby agrees, that notwithstanding anything contained in any restricted stock award agreement, the Employment Agreement, or any other agreement, the unvested
shares of restricted stock held by Executive as of Termination Date shall be forfeited immediately as of such date. 

  


					
	         Executive Initials	  	9